The U.S. Food and Drug Administration (FDA) has granted traditional approval to Jaypirca (pirobrutinib) for the treatment of ...
Emotional readiness often lags behind intellectual awareness, leaving individuals unprepared for a cancer diagnosis. Support ...
When Gleevec was invented, or when it came out, that was a game-changer for patients with GIST, because they previously had ...
TARA-002 demonstrates high complete response rates in BCG-naïve NMIBC patients, with 72% achieving CR and 50% maintaining it ...
One of biggest stories or developments in acute myeloid leukemia or AML is the wider adoption and use of the regimen of ...
The oncologist's innovative thinking and deep knowledge provided hope and improved the patient's quality of life. I’ve lived ...
As part of her journey with stage 3 inflammatory breast cancer, Lindsey Gunter experienced chemotherapy side effects so ...
The U.S. Food and Drug Administration (FDA) has approved Breyanzi (lisocabtagene maraleucel) for the treatment of adults with relapsed or refractory marginal zone lymphoma who have received at least ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback